<DOC>
	<DOCNO>NCT01462201</DOCNO>
	<brief_summary>The primary objective study evaluate effectiveness Contour I VER 3.1 System abdominal midsection circumference reduction relative treatment . The secondary objective study ass subject satisfaction measure self-assessment questionnaire</brief_summary>
	<brief_title>A Multicenter,2-Arm , Randomized , Controlled Study Evaluate Effectiveness UltraShape® Contour I VER 3.1 System Non-Invasive Reduction Abdominal Circumference</brief_title>
	<detailed_description />
	<criteria>1 . Female male subject , 18 65 year age time enrollment 2 . Abdominal fat thickness least 1.5 cm ( measurement caliper ) 3 . For woman childbearing potential : 1. negative urine pregnancy test . 2 . Women child bear age require use acceptable form birth control duration study . 4 . General good health confirm medical history skin examination treat area 5 . Written inform consent participate study 6 . Ability comply requirement study 7 . BMI ≤ 30 Intraprocedural Inclusion criterion ( prior start treatment phase ) : subject eligible continue study participate treatment phase meet follow intraprocedural inclusion criterion : 8 . For woman childbearing potential : negative pregnancy test 9 . Abdominal fat thickness least 1.5 cm prior initial treatment ( measurement caliper ) 1 . History hypertension , ischemic heart disease , valvular heart disease , congestive heart failure , pacemaker/defibrillator , abdominal aortic aneurysm 2 . Current hyperlipidemia , diabetes mellitus , hepatitis , liver disease , HIV positive status , blood coagulopathy excessive bleeding , autoimmune connective tissue disease malignancy . 3 . Previous liposuction treatment area 4 . History skin disease treatment area , know tendency form keloid poor wound heal 5 . Skin lesion treatment area simple nevi physical examination ( e.g. , atypical nevus , tattoo , abrasion ) include depressed scar treatment area 6 . Poor skin quality ( i.e. , laxity ) 7 . Abdominal wall diastasis hernia physical examination 8 . Abnormal kidney , liver coagulation function , abnormal lipid profile blood count within last 3 month 9 . Obesity ( BMI &gt; 30 ) 10 . Childbirth within last 12 month breastfeed woman . 11 . Any acute chronic condition , opinion Investigator , could interfere conduct study 12 . Unstable weight within last 6 month ( i.e. , ± 3 % weight change prior six month ) 13 . Inability comply circumference measurement procedure ( e.g. , inability hold breath require duration ) 14 . Participation another clinical study within last six month . 15 . Previous body contour treatment area abdomen flank .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>focus ultrasound</keyword>
	<keyword>mechanical fat destruction</keyword>
	<keyword>Body Sculpting</keyword>
</DOC>